Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
February 2004
Features
Book Review
Dr. David Sherer’s Hospital Survival Guide
A valuable book provides practical advice for readers and their families about how to prepare for surgery.
Adam Evans
Focus on Medicare
Medicare and the New Generic Drug Legislation
Dr. Goldenberg discusses how Hatch–Waxman “got the hatchet.”
Marvin M. Goldenberg, PhD, RPh, MS
The Medicare Modernization Act (MMA): How Will It Affect P&T Committee Members?
Dr. Stefanacci addresses some unanswered questions about the new Medicare drug benefit; for example, how many drugs will be needed to meet the formulary requirement, how will the formularies be designed, and how will the appeals process work?
Richard G. Stefanacci, DO, MGH, MBA, CMD
Meeting Highlights
Highlights of the 45th Annual Meeting of the American Society of Hematology
Dr. Prescott reports on new therapies for non-Hodgkin’s and mantle-cell lymphomas, myeloid and myelomonocytic leukemias, myelodysplastic syndromes, myelodysplasia, oral mucositis, polycythemia vera, and other disorders of the blood.
Lawrence M. Prescott, PhD
Continuing Education Credit
Current Recommendations for the Treatment of Dyslipidemia
Dr. Talbert reviews current therapies for lipid disorders and emphasizes the need for monitoring patients and promoting their adherence to treatment guidelines.
Robert L. Talbert, PharmD, BCPS
CE Forms and Test for “Current Recommendations for the Treatment of Dyslipidemia”
Departments
Editorial
Seeking Middle Ground
David Nash, MD, MBA, discusses the need for health care providers and drug companies to “seek middle ground” in avoiding conflicts of interest.
David B. Nash, MD, MBA
Prescription Washington
House of Cards: New Medicare Drug Cards Built on Rickety Assumptions
Stephen Barlas perceives some pitfalls with the new Medicare Drug Discount Cards.
Stephen Barlas
Medication Errors
Maintaining Patient Safety in the Midst of Staff Reductions
Matthew Grissinger, RPh, FASCP, stresses the need to maintain patient safety despite the current trend of staff reductions.
Matthew Grissinger, RPh, FASCP
P&T Snapshot
Hospital Treatment Patterns for Dyslipidemia
Drug News
New Drugs/Drug News
P&T presents the latest studies and information about FDA approvals, drug indications, industry updates, and new medical devices.
Drug Forecast
FluMist™: A Live, Attenuated Influenza Vaccine
Drs. Hilas and Marzella review FluMist™, a live, attenuated influenza vaccine.
Olga Hilas, BS, PharmD, and Nino Marzella, BS, PharmD
